Ikena Oncology Inc (IKNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IKNA | BMY | AMGN | GILD | REGN |
| Company | Ikena Oncology Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.2400 | 47.93 | 265.64 | 67.01 | 901.26 |
| High | 1.2900 | 48.20 | 265.92 | 67.02 | 908.81 |
| Low | 1.2200 | 47.62 | 262.75 | 65.90 | 891.67 |
| Last | 1.2650 | 48.06 | 263.21 | 66.07 | 897.70 |
| Change | +0.0250 | +0.22 | -0.86 | -0.86 | -3.49 |
| % Change | +2.02% | +0.46% | -0.33% | -1.28% | -0.39% |
| Volume | 61,667 | 5,059,927 | 713,831 | 3,123,190 | 200,267 |
| 20-Day Average Volume | 309,138 | 11,106,320 | 2,130,497 | 6,040,839 | 420,885 |
| Previous Close | 1.2400 | 47.84 | 264.07 | 66.93 | 901.19 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.3533 | 50.97 | 273.00 | 70.21 | 938.97 |
| 20-Day Raw Stochastic | 11.84% | 4.89% | 2.48% | 2.86% | 9.09% |
| 20-Day Relative Strength | 41.61% | 35.42% | 37.11% | 27.86% | 34.46% |
| Weighted Alpha | -51.71 | -30.84 | +4.61 | -25.30 | +12.73 |
| Today's Opinion | 100% Sell | 72% Sell | 56% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 100% Sell | 56% Sell | 56% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 56% Sell | 24% Sell | 8% Sell | 88% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.33% since 04/11/24 | -2.36% since 04/11/24 | -2.45% since 04/11/24 | -3.66% since 04/11/24 | -2.37% since 04/11/24 |
| Low | 1.2200 on 04/18/24 | 47.63 on 04/18/24 | 262.75 on 04/18/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 1.3900 on 04/12/24 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 68.62 on 04/12/24 | 921.12 on 04/15/24 |
| 1-Month | |||||
| %Chg | -15.67% since 03/18/24 | -7.04% since 03/18/24 | -2.77% since 03/18/24 | -9.72% since 03/18/24 | -6.40% since 03/18/24 |
| Low | 1.2200 on 04/18/24 | 47.63 on 04/18/24 | 262.75 on 04/18/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 1.6000 on 03/21/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 979.26 on 03/21/24 |
| 3-Month | |||||
| %Chg | -22.87% since 01/18/24 | -4.25% since 01/18/24 | -13.50% since 01/18/24 | -23.45% since 01/18/24 | -3.39% since 01/18/24 |
| Low | 1.2200 on 04/18/24 | 47.58 on 02/06/24 | 262.75 on 04/18/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 1.7800 on 01/19/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -66.62% since 10/18/23 | -15.64% since 10/18/23 | -7.12% since 10/18/23 | -16.98% since 10/18/23 | +8.77% since 10/18/23 |
| Low | 1.0200 on 11/09/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 769.19 on 10/27/23 |
| High | 4.6250 on 11/03/23 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 59,840 | 96,960,152 | 141,520,144 | 83,333,008 | 98,916,416 |
| Shares Outstanding, K | 48,258 | 2,026,759 | 535,919 | 1,245,077 | 109,762 |
| Annual Sales | 9,160,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -68,170,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 660,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -19,490,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 0.33 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.41 on 03/12/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/20/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.43 | 14.24 | 10.02 | 23.79 |